Article Text

PDF
SAT0052 TNFγ adherent BM-DC efficiently inhibit collagen-induced- arthritis, and delayed skin graft rejection in mouse
  1. L. Brikci-Nigassa1,2,
  2. J.-L. Touraine2,
  3. P. Miossec1,
  4. A. Eljaafari1
  1. 1Immunogenomics and Inflammation Unit
  2. 2Immunology and Transplantation, Hospices Civils De Lyon, Lyon, France

Abstract

Background Rheumatoid Arthritis (RA) is a chronic inflammatory disease, initiated by a break in self-tolerance. Tolerogenic dendritic cells (Tol-DC) are involved in the maintenance of tolerance to antigen, but are deficient in RA.

Objectives Our ultimate objective is to use Tol-DC for the treatment of patients with severe refractory RA. Therefore, in this project, we aimed to validate this approach by evaluating the therapeutic action of Tol-DCs in a type II collagen-induced arthritis murine model

Methods We have previously reported that DC mediated by IFNg plus GM-IL4 are tolerogenic in human (1). Herein, mouse Tol-DC were prepared by using this protocol, except that bone-marrow mononuclear cells were used instead of blood monocytes. Arthritis was induced with 100 μg of type II collagen in 8–10-week-old DBA/1 mice, following two steps of sensitization and induction. Allogenic skin transplantation was performed by using Balb/c mice, which received skin graft from DBA/1 mice, after sublethal irradiation

Results In contrast to human, IFNγ-treated DC did not resist to maturation in mouse, but died, probably by exhaustion. Moreover, treatment of bone marrow cells with GM-IL4 resulted in the appearance of adherent DC in mouse, but not in human Maturation of mouse adherent-DC with TNFa induced them to exert tolerogenic properties, in-vitro. In vivo, those cells inhibited collagen induced arthritis (p<0.01, at D57, and D65), following their intra-peritoneal injection at the concentration of 2×105, at the time of induction with collagen. Such induction of tolerance was confirmed in a skin graft mouse model, where rejection was delayed from day 8.5 to day 14.7, following only one injection of TNFa-adherent DC.

Conclusions We demonstrate herein that TNFa-adherent DC are endowed with efficient tolerogenic properties in mouse, but point out major differences between mouse and human in the generation of Tol-DC. Indeed, GM-IL4 induced the appearance of adherent BM-DCs in mouse but not in human, whereas IFNg induced Tol-DC in human, but not in mouse. These results underline thus the difficulties to predict the beneficial effects of such cell therapies in human, by using rodent studies.

  1. Assia Eljaafari; Yin-Ping Li; Pierre Miossec. J.Immunol: 2009;183:2932-45.

Disclosure of Interest None Declared

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.